Report - 208673Orig1s000 - Food and Drug Administration...Applicant Sanofi-aventis U.S. LLC Formulation(s) Injection Dosing Regimen Once-daily, sub-cutaneous (s.c.) Indication(s) Treatment

Please pass captcha verification before submit form